RET and cancer: Prioritized cancer drivers not previously reported in OS included RET, MUTYH, NUMA1, FANCA, BRCA2 and ATM. We chose these genes for further investigation, based on the presence of at least two clearly pathogenic mutations and/or co-segregation of mutations with cancer in the respective families.